Skin cancer in patients with non-Hodgkins lymphoma

Jerry D. Brewer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There has been a well-documented association between non-Hodgkins lymphoma, including chronic lymphocytic leukemia, and melanoma as well as non-melanoma skin cancers. In addition, there have been multiple reports documenting aggressive skin cancers in the setting of lymphoma. This article highlights the existing data in regards to the association between non-Hodgkins lymphoma/chronic lymphocytic leukemia and the common forms of skin cancer. Patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop non-melanoma skin cancer have worse outcomes demonstrated by increased rates of local recurrence, regional metastasis and death. Similarly, patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop melanoma have demonstrated trends towards worse outcomes, including a possible increased risk towards recurrence, metastasis and melanoma-specific mortality. Common forms of skin cancer may share genetic aberrations with lymphoma, which may be one of the reasons behind the causal relationship that has been documented between these two forms of malignancy. These commonly shared genetic aberrations may also contribute to the increased aggressiveness seen in lymphoma-associated skin cancer. Patients who have lymphoma-associated skin cancer should undergo aggressive treatment approaches to decrease the chances of recurrence and skin cancer-associated morbidity and mortality. Preventive strategies, such as early detection, sun-protective behavior, frequent dermatologic examinations and education directed toward the patient with lymphoma, may not only prevent the development of aggressive skin cancer, but also have a higher rate of successfully treating early forms of skin cancer in this high-risk patient population.

Original languageEnglish (US)
Pages (from-to)525-533
Number of pages9
JournalExpert Review of Dermatology
Volume5
Issue number5
DOIs
StatePublished - Oct 2010

Fingerprint

Skin Neoplasms
Non-Hodgkin's Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Melanoma
Recurrence
Neoplasm Metastasis
Mortality
Solar System
Morbidity
Education

Keywords

  • basal cell carcinoma
  • chronic lymphocytic leukemia
  • epidemiology
  • genetics
  • malignant melanoma
  • Merkel cell carcinoma
  • non-Hodgkins lymphoma
  • prognosis
  • skin cancer
  • squamous cell carcinoma

ASJC Scopus subject areas

  • Dermatology

Cite this

Skin cancer in patients with non-Hodgkins lymphoma. / Brewer, Jerry D.

In: Expert Review of Dermatology, Vol. 5, No. 5, 10.2010, p. 525-533.

Research output: Contribution to journalArticle

Brewer, Jerry D. / Skin cancer in patients with non-Hodgkins lymphoma. In: Expert Review of Dermatology. 2010 ; Vol. 5, No. 5. pp. 525-533.
@article{cf3048ddba5b4c628f3c419421bdb69d,
title = "Skin cancer in patients with non-Hodgkins lymphoma",
abstract = "There has been a well-documented association between non-Hodgkins lymphoma, including chronic lymphocytic leukemia, and melanoma as well as non-melanoma skin cancers. In addition, there have been multiple reports documenting aggressive skin cancers in the setting of lymphoma. This article highlights the existing data in regards to the association between non-Hodgkins lymphoma/chronic lymphocytic leukemia and the common forms of skin cancer. Patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop non-melanoma skin cancer have worse outcomes demonstrated by increased rates of local recurrence, regional metastasis and death. Similarly, patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop melanoma have demonstrated trends towards worse outcomes, including a possible increased risk towards recurrence, metastasis and melanoma-specific mortality. Common forms of skin cancer may share genetic aberrations with lymphoma, which may be one of the reasons behind the causal relationship that has been documented between these two forms of malignancy. These commonly shared genetic aberrations may also contribute to the increased aggressiveness seen in lymphoma-associated skin cancer. Patients who have lymphoma-associated skin cancer should undergo aggressive treatment approaches to decrease the chances of recurrence and skin cancer-associated morbidity and mortality. Preventive strategies, such as early detection, sun-protective behavior, frequent dermatologic examinations and education directed toward the patient with lymphoma, may not only prevent the development of aggressive skin cancer, but also have a higher rate of successfully treating early forms of skin cancer in this high-risk patient population.",
keywords = "basal cell carcinoma, chronic lymphocytic leukemia, epidemiology, genetics, malignant melanoma, Merkel cell carcinoma, non-Hodgkins lymphoma, prognosis, skin cancer, squamous cell carcinoma",
author = "Brewer, {Jerry D.}",
year = "2010",
month = "10",
doi = "10.1586/edm.10.48",
language = "English (US)",
volume = "5",
pages = "525--533",
journal = "Expert Review of Dermatology",
issn = "1746-9872",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Skin cancer in patients with non-Hodgkins lymphoma

AU - Brewer, Jerry D.

PY - 2010/10

Y1 - 2010/10

N2 - There has been a well-documented association between non-Hodgkins lymphoma, including chronic lymphocytic leukemia, and melanoma as well as non-melanoma skin cancers. In addition, there have been multiple reports documenting aggressive skin cancers in the setting of lymphoma. This article highlights the existing data in regards to the association between non-Hodgkins lymphoma/chronic lymphocytic leukemia and the common forms of skin cancer. Patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop non-melanoma skin cancer have worse outcomes demonstrated by increased rates of local recurrence, regional metastasis and death. Similarly, patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop melanoma have demonstrated trends towards worse outcomes, including a possible increased risk towards recurrence, metastasis and melanoma-specific mortality. Common forms of skin cancer may share genetic aberrations with lymphoma, which may be one of the reasons behind the causal relationship that has been documented between these two forms of malignancy. These commonly shared genetic aberrations may also contribute to the increased aggressiveness seen in lymphoma-associated skin cancer. Patients who have lymphoma-associated skin cancer should undergo aggressive treatment approaches to decrease the chances of recurrence and skin cancer-associated morbidity and mortality. Preventive strategies, such as early detection, sun-protective behavior, frequent dermatologic examinations and education directed toward the patient with lymphoma, may not only prevent the development of aggressive skin cancer, but also have a higher rate of successfully treating early forms of skin cancer in this high-risk patient population.

AB - There has been a well-documented association between non-Hodgkins lymphoma, including chronic lymphocytic leukemia, and melanoma as well as non-melanoma skin cancers. In addition, there have been multiple reports documenting aggressive skin cancers in the setting of lymphoma. This article highlights the existing data in regards to the association between non-Hodgkins lymphoma/chronic lymphocytic leukemia and the common forms of skin cancer. Patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop non-melanoma skin cancer have worse outcomes demonstrated by increased rates of local recurrence, regional metastasis and death. Similarly, patients with non-Hodgkins lymphoma/chronic lymphocytic leukemia who subsequently develop melanoma have demonstrated trends towards worse outcomes, including a possible increased risk towards recurrence, metastasis and melanoma-specific mortality. Common forms of skin cancer may share genetic aberrations with lymphoma, which may be one of the reasons behind the causal relationship that has been documented between these two forms of malignancy. These commonly shared genetic aberrations may also contribute to the increased aggressiveness seen in lymphoma-associated skin cancer. Patients who have lymphoma-associated skin cancer should undergo aggressive treatment approaches to decrease the chances of recurrence and skin cancer-associated morbidity and mortality. Preventive strategies, such as early detection, sun-protective behavior, frequent dermatologic examinations and education directed toward the patient with lymphoma, may not only prevent the development of aggressive skin cancer, but also have a higher rate of successfully treating early forms of skin cancer in this high-risk patient population.

KW - basal cell carcinoma

KW - chronic lymphocytic leukemia

KW - epidemiology

KW - genetics

KW - malignant melanoma

KW - Merkel cell carcinoma

KW - non-Hodgkins lymphoma

KW - prognosis

KW - skin cancer

KW - squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=77958059270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958059270&partnerID=8YFLogxK

U2 - 10.1586/edm.10.48

DO - 10.1586/edm.10.48

M3 - Article

AN - SCOPUS:77958059270

VL - 5

SP - 525

EP - 533

JO - Expert Review of Dermatology

JF - Expert Review of Dermatology

SN - 1746-9872

IS - 5

ER -